openPR Logo
Press release

Fabry Disease Treatment Market 2019-2026 Global Industry Scope, Trend, Share, Key Vendors (Sanofi-Aventis LLC, iBio, Inc., GlaxoSmithKline plc., Genzyme Corporation, Neuraltus Pharmaceuticals, Inc.)

06-18-2019 12:27 PM CET | Health & Medicine

Press release from: Orian Research

Fabry Disease Treatment Market

Fabry Disease Treatment Market

The Global Fabry Disease Treatment Market was estimated to be valued at USD XX million in 2019 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The global Fabry Disease Treatment market is primarily segmented based on different deployment, end-user, and regions.

Get Sample Copy of this Report @ https://www.orianresearch.com/request-sample/1064668

Expanding base of patients suffering with fabry disease coupled with increased adoption of novel therapies such as chaperone treatment has helped the market gain momentum. However, lack of awareness about advancements in genetic sciences may hamper the market growth in the forecast period.

The key players profiled in the market include:
• Sanofi-Aventis LLC, iBio, Inc. GlaxoSmithKline plc., Genzyme Corporation, Neuraltus Pharmaceuticals, Inc., Novartis Pharmaceuticals, Merck & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc. and Amgen Inc.

On the basis of types, the market is split into:
• Enzyme Replacement Therapy (ERT)
• Substrate Reduction Therapy (SRT)
• Chaperone Treatment
• Analgesics
• Anticonvulsants
• NSAIDs

On the basis of applications, the market is split into:
• Hospital
• Clinics

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Global Fabry Disease Treatment Market is spread across 121 pages

Inquire more or share questions if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/1064668

Key Benefits of the Report:
• Global, regional, country, product type, and application market size and their forecast from 2014-2025
• Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
• Detailed analysis on industry outlook with market specific Porter’s Five Forces analysis, PESTLE analysis, and Value Chain, to better understand the market and build expansion strategies
• Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
• Analysis on key player’s strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
• Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors short term and long term strategies
• Detailed insights on emerging regions, product types, applications with qualitative and quantitative information and facts
• Identification of the key patents filed in the field of Fabry Disease Treatment

Target Audience:
• Fabry Disease Drug Manufacturers
• Raw Materials Suppliers & Distributors
• Government and Research Organizations
• Pharmaceutical & Biotechnology Companies

Order a Copy of this Report @ https://www.orianresearch.com/checkout/1064668

Table Of Content:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Global Fabry Disease Treatment Market Overview
5. Global Fabry Disease Treatment Market, by Therapy
6. Global Fabry Disease Treatment Market, by End-User
7. Global Fabry Disease Treatment Market, by Region
8. Competitive Landscape
9. Company Profiles
10. Key Insights

Contact Us:
Ruwin Mendez
Vice President – Global Sales & Partner Relations
Orian Research Consultants
US +1 (415) 830-3727 | UK +44 020 8144-71-27
Email: info@orianresearch.com
Website: www.orianresearch.com/
Follow Us on LinkedIn: www.linkedin.com/company-beta/13281002/

About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fabry Disease Treatment Market 2019-2026 Global Industry Scope, Trend, Share, Key Vendors (Sanofi-Aventis LLC, iBio, Inc., GlaxoSmithKline plc., Genzyme Corporation, Neuraltus Pharmaceuticals, Inc.) here

News-ID: 1779114 • Views:

More Releases from Orian Research

Adaptive Optics Market Size, Competitive Analysis, Share, Forecast- 2019-2025
Adaptive Optics Market Size, Competitive Analysis, Share, Forecast- 2019-2025
The global adaptive optics market is projected to grow at a significant CAGR of 39.7% during the forecast period owing to the increasing application of adaptive optics in retinal imaging and ophthalmology to reduce the optical aberrations. The integration of adaptive optics converts an ophthalmoscope into a microscope, allowing visualization of and optical access to individual retinal cells in living human eyes. To learn more about this report request a
Supply Chain Analytics Market Size, Competitive Analysis, Share, Forecast- 2019-2025
Supply Chain Analytics Market Size, Competitive Analysis, Share, Forecast- 2019- …
The Global Supply Chain Analytics Market is estimated to grow at a significant CAGR during the forecast period 2019- 2025. The impact of e-commerce on retailers and manufacturers is driving a revolution in many sectors and business organization. This has led to the introduction of supply chain analytics solution, which offers mathematics, statistics, predictive modeling and machine-learning techniques to find meaningful patterns and knowledge regarding order, shipment and transactional data.
Laparoscopic Instruments Market Size, Competitive Analysis, Share, Forecast- 2018-2023
Laparoscopic Instruments Market Size, Competitive Analysis, Share, Forecast- 201 …
The laparoscopic or minimally invasive surgery uses a special surgical instrument known as laparoscope to look inside the body and carry out certain procedures. The laparoscopic instruments market is projected to witness a steady growth rate during the forecast period 2018-2023. The rise in preference of minimal invasive method over invasive surgeries, the high prevalence of lifestyle-oriented diseases, high global expenditure on the laparoscopic market, increasing healthcare market in emerging
Fertility Drug Market Size, Competitive Analysis, Share, Forecast- 2018-2023
Fertility Drug Market Size, Competitive Analysis, Share, Forecast- 2018-2023
Infertility is one of the major issue now a day due to change in life style & cultural shift. There are various fertility drugs available in market for infertility related problems. Fertility drugs enhance the reproductive ability by improving quality of egg or sperms by increasing the levels of certain hormones in human body. The major factors that are responsible for the growth of fertility drug market are Change in

All 5 Releases


More Releases for Fabry

U.S. Fabry Disease Market Size Report 2034
On April 28, 2025, Exactitude Consultancy., Ltd. released a research report titled "U.S. Fabry Disease Market". This report covers the global U.S. Fabry Disease market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.
Top Factor Driving Fabry Disease Treatment Market Growth in 2025: Impact of Incr …
How Are the key drivers contributing to the expansion of the fabry disease treatment market? The rising prevalence of renal diseases is expected to drive the growth of the Fabry disease treatment market. Renal diseases are becoming more prevalent due to genetic factors, lifestyle choices, and environmental influences. Fabry disease, which causes kidney dysfunction, is increasing and requires timely intervention. According to the Australian Bureau of Statistics, kidney disease affected 246,200
Fabry Disease Market Trends Analysis 2030
Fabry disease is a rare X-linked lysosomal storage disorder. This patient has a deficiency in the enzyme alpha galactosidase, which progresses to organ failure. The development of fabry illnesses is mostly caused by abnormal accumulation of a certain fatty substance known as globotriaosylceramide. This aberrant buildup can be detected in the skin, eyes, heart, kidney, brain, gastrointestinal system, and central nervous system, among other body parts. Galactosidase Alpha (GLA) is a
Fabry Disease Market Pipeline 2019 Analysis and Developmental Stages
"Fabry Disease - Pipeline Insight, 2019” report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fabry Disease development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages: - Clinical - Non-clinical - Inactive: Discontinued
Fabry Disease - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Fabry Disease - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fabry Disease - Pipeline Review, H1 2017, provides an overview of the Fabry Disease (Genetic Disorders) pipeline landscape. Fabry disease is an inherited disorder. Fabry disease results from abnormal deposits of a particular fatty substance (called
Fabry Disease Market Intelligence Report Offers Growth Prospects
Fabry diseaseis also known as Anderson-Fabry disease and alpha-galactosidase A deficiency. It is a rare genetic disorder of lipid metabolism resulting from the deficient activity of the alpha-galactosidase A (a-Gal A) enzyme. The deficiency of the enzyme is caused by the alterations in the genes that instructs the cells to make alpha-galactosidase A (a-Gal A) enzyme. Fabry disease is known to cause variety of systemic symptoms and complications, one of